Development and Validation of a Prevalence Model for Latent Autoimmune Diabetes in Adults (LADA) Among Patients First Diagnosed with Type 2 Diabetes Mellitus (T2DM)

Zhida Wang; Jie Zhang; Hui Xu; Liming Chen; Abigail Dove

doi:10.12659/MSM.932725

15 September 2021: Clinical Research

Development and Validation of a Prevalence Model for Latent Autoimmune Diabetes in Adults (LADA) Among Patients First Diagnosed with Type 2 Diabetes Mellitus (T2DM)

Zhida Wang ^1ABCDEF* , Jie Zhang ^2ABCDEF* , Hui Xu ^3CDEF , Liming Chen ^1ADEFG* , Abigail Dove ^4ADEF

DOI: 10.12659/MSM.932725

Med Sci Monit 2021; 27:e932725

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 1 ROC curve of the predicted model in the validation group. (The probability prediction of the predicted model distinguishing LADA patients among diabetes patients in adults was 0.757)

Back to the Article

Development and Validation of a Prevalence Model for Latent Autoimmune Diabetes in Adults (LADA) Among Patients First Diagnosed with Type 2 Diabetes Mellitus (T2DM)

Your Privacy